Since 2018
• Graham, O. E. E., Pitcher, T. L., Liau, Y., Miller, A. L., Dalrymple-Alford, J. C., Anderson, T. J. and Kennedy, M. A. (2020). Nanopore sequencing of the glucocerebrosidase (GBA) gene in a New Zealand Parkinson's disease cohort. Parkinsonism Relat Disord 70: 36-41.
• Krishnamurthi, R. V., Barker-Collo, S., Barber, P. A., Tippett, L. J., Dalrymple-Alford, J. C., Tunnage, B., Mahon, S., Parmar, P. G., Moylan, M. and Feigin, V. L. (2020). Community Knowledge and Awareness of Stroke in New Zealand. J Stroke Cerebrovasc Dis 29(3): 104589.
• Nalls, M. A., Blauwendraat, C., Vallerga, C. L., Heilbron, K., Bandres-Ciga, S., Chang, D., Tan, M., Kia, D. A., Noyce, A. J., Xue, A., Bras, J. et al. (2019). Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet Neurol 18(12): 1091-1102.
• Alamri, Y., Pascoe, M., MacAskill, M., Anderson, T. and Dalrymple-Alford, J. (2019). Sensorimotor integration assessment by the Symbol-Digit modalities test in patients with Parkinsons disease. Neurosciences (Riyadh) 24(2): 143-144.
• Hoogland, J., Boel, J. A., de Bie, R. M., Schmand, B. A., Geskus, R. B., Dalrymple‐Alford, J. C., Marras, C., Adler, C. H., Weintraub, D., Junque, C., Pedersen, K. F., Mollenhauer, B., Zabetian, C. P., Eslinger, P. J., Lewis, S. J. G., Wu, R-M., Klein, M., Rodriguez‐Oroz, M. C., Cammisuli, D. M., Barone, P., Biundo, R., de Bie, R. M. A., Schmand, B. A., Tröster, A. I., Burn, D. J., Litvan, I., Filoteo, J. V., Geurtsen, G. J., Weintraub, D., IPMDS Study Group “Validation of Mild Cognitive Impairment in Parkinson Disease”. Risk of Parkinson's disease dementia related to level I MDS PD‐MCI. Movement Disorders. 2019 Mar;34(3):430-5.
• Graham, O. E. E., Pitcher, T. L., Liau, Y., Miller, A. L., Dalrymple-Alford, J. C., Anderson, T. J. and Kennedy, M. A. (2020). Nanopore sequencing of the glucocerebrosidase (GBA) gene in a New Zealand Parkinson's disease cohort. Parkinsonism Relat Disord 70: 36-41.
• Krishnamurthi, R. V., Barker-Collo, S., Barber, P. A., Tippett, L. J., Dalrymple-Alford, J. C., Tunnage, B., Mahon, S., Parmar, P. G., Moylan, M. and Feigin, V. L. (2020). Community Knowledge and Awareness of Stroke in New Zealand. J Stroke Cerebrovasc Dis 29(3): 104589.
• Nalls, M. A., Blauwendraat, C., Vallerga, C. L., Heilbron, K., Bandres-Ciga, S., Chang, D., Tan, M., Kia, D. A., Noyce, A. J., Xue, A., Bras, J. et al. (2019). Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet Neurol 18(12): 1091-1102.
• Ulrich, K., Spriggs, M. J., Abraham, W. C., Dalrymple-Alford, J. C. and McNaughton, N. (2019). Environmental enrichment increases prefrontal EEG power and synchrony with the hippocampus in rats with anterior thalamus lesions. Hippocampus 29(2): 128-140.
• Melzer, T. R., Stark, M. R., Keenan, R. J., Myall, D. J., MacAskill, M. R., Pitcher, T. L., Livingston, L., Grenfell, S., Horne, K. L., Young, B. N., Pascoe, M. J., Almuqbel, M. M., Wang, J., Marsh, S. H., Miller, D. H., Dalrymple-Alford, J. C. and Anderson, T. J. (2019). Beta Amyloid Deposition Is Not Associated With Cognitive Impairment in Parkinson's Disease. Front Neurol 10: 391.
• Grasby, K. L., Jahanshad, N., Painter, J. N., Colodro-Conde, L., Bralten, J., Hibar, D. P., Lind, P. A., Pizzagalli, F., Ching, C. R. K., McMahon, M. A. B., Shatokhina, N. et al. (2018). The genetic architecture of the human cerebral cortex. bioRxiv.
• Castellazzi, G., Debernard, L., Melzer, T. R., Dalrymple-Alford, J. C., D'Angelo, E., Miller, D. H., Gandini Wheeler-Kingshott, C. A. M. and Mason, D. F. (2018). Functional Connectivity Alterations Reveal Complex Mechanisms Based on Clinical and Radiological Status in Mild Relapsing Remitting Multiple Sclerosis. Front Neurol 9: 690.
• Dalrymple-Alford, J. C. and Perry, B. A. L. (2018). Lesions of the mammillothalamic tract and anterior thalamic nuclei: Response to Vann and Nelson (2018). Hippocampus 28(10): 694-697.
• Pitcher, T. L., Myall, D. J., Pearson, J. F., Lacey, C. J., Dalrymple-Alford, J. C., Anderson, T. J. and MacAskill, M. R. (2018). Parkinson's disease across ethnicities: A nationwide study in New Zealand. Mov Disord 33(9): 1440-1448.
• Horne, K. L., Myall, D. J., MacAskill, M. R., Anderson, T. J. and Dalrymple-Alford, J. C. (2018). Response to "Parkinson's disease mild cognitive impairment classifications and neurobehavioral symptoms". Int Psychogeriatr 30(9): 1415.
• Barnett, S. C., Perry, B. A. L., Dalrymple-Alford, J. C. and Parr-Brownlie, L. C. (2018). Optogenetic stimulation: Understanding memory and treating deficits. Hippocampus 28(7): 457-470.
• Fan, D., Alamri, Y., Liu, K., MacAskill, M., Harris, P., Brimble, M., Dalrymple-Alford, J., Prickett, T., Menzies, O., Laurenson, A., Anderson, T. and Guan, J. (2018). Supplementation of Blackcurrant Anthocyanins Increased Cyclic Glycine-Proline in the Cerebrospinal Fluid of Parkinson Patients: Potential Treatment to Improve Insulin-Like Growth Factor-1 Function. Nutrients 10(6).
• Perry, B. A. L., Mercer, S. A., Barnett, S. C., Lee, J. and Dalrymple-Alford, J. C. (2018). Anterior thalamic nuclei lesions have a greater impact than mammillothalamic tract lesions on the extended hippocampal system. Hippocampus 28(2): 121-135.
• Rapley, S. A., Prickett, T. C. R., Dalrymple-Alford, J. C. and Espiner, E. A. (2018). Environmental Enrichment Elicits a Transient Rise of Bioactive C-Type Natriuretic Peptide in Young but Not Aged Rats. Front Behav Neurosci 12: 142.
• Pascoe, M., Alamri, Y., Dalrymple-Alford, J., Anderson, T. and MacAskill, M. (2018). The Symbol-Digit Modalities Test in Mild Cognitive Impairment: Evidence from Parkinson's Disease Patients. Eur Neurol 79(3-4): 206-210.